ALLERGIC RHINITIS TREATMENT MARKET ANALYSIS

Allergic Rhinitis Treatment Market, By Treatment Type (Immunotherapy (Sub-cutaneous Immunotherapy, Sub-lingual Immunotherapy), Anti-histamines, Decongestants, Leukotriene Receptor Antagonists, Corticosteroids, and Others), By Route of Administration (Oral, Nasal, Intraocular, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-commerce), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024
Code : CMI1201
Pages :181
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Allergic Rhinitis Treatment Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing Prevalence of Allergic Rhinitis

Growing industrialization and urbanization have led to higher concentrations of outdoor allergens like pollen, mold, dust, and animal dander in the air. At the same time, people are spending more time indoors where indoor allergens from furnishings, cleaning products, and other materials are present. This has increased individual's exposure and susceptibility to develop allergic rhinitis. Thus, the increasing prevalence of allergic rhinitis boosts the demand for effective treatment which is expected to drive the market growth over the forecast period. For instance, according to the World Allergy Organization report in October 2020, over 400 million people suffer from allergic rhinitis around the world, which to a large extent remains underdiagnosed and undertreated. In the U.S., it affects between 10-30% of the adult general population and up to 40% of children, making it the fifth most common chronic disease.

Key Players Insights